Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Unstable angina and NSTEMI
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI )
Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium.
Optimal Timing of PCI in ACS Patrick Hildbrand. Trends and Prognosis in ACS Furman MI, JACC 2001, 37: Hospital 1 year.
“ If physicians would read two articles per day out of the six million medical articles published annually, in one year, they would fall 82 centuries behind.
Update on the Medical Management of Acute Coronary Syndrome.
A Risk Score for Predicting Coronary Artery Bypass Surgery in Patients with Non-ST Elevation Acute Coronary Syndromes Sai Sadanandan, MD*; Christopher.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
Myocardial Infarction
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Internal Medicine Board Review: Cardiology Acute Coronary Syndrome Christine Nardi May 20, 2009.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
Indication and contra-indications for cardiac catheterization
Chest Pain & Unstable Angina Eugene Yevstratov MD Based on UCLA protocol of the management of Chest Pain & Unstable Angina.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
New Treatment Advances in Acute Coronary Syndrome.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Silent Ischemia STABLE CAD
“Challenging practice in non-ST segment elevation Acute Coronary Syndromes (ACS)” Professor Jennifer Adgey Royal Victoria Hospital, Belfast 26th January.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
Update of 2013 ACCF/AHA Guidelines for STEMI Junbo Ge MD,FACC,FESC,FSCAI Zhongshan Hospital, Fudan University.
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
TACTICS- TIMI 18 Treat Angina with Aggrastat TM and Determine Cost of Therapy with an Invasive or Conservative Strategy.
Antiplatelet Interventions in Acute Coronary Syndromes.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.
Annual Patient Admissions for Acute Coronary Syndromes 1.4 MM Non-ST elevation ACS 0.6 MM ST-elevation MI ~ 2.0 MM patients admitted to CCU or telemetry.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: The thrombolysis in myocardial infarction risk score.
Date of download: 5/28/2016 From: Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review.
Dr.Ali Eshraghi MD Interventional Cardiologist Non STE ACS  Angiographic Findings: 34% 3VD 28%2VD 26%SVD 10%LMCAD Culprit lesion charactristic: eccentric,scalloped,evidence.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: A guide to therapeutic decision-making in patients.
Invasive Versus Conservative Strategy in Patients Aged 80 years or Older with NSTEMI or Unstable Angina(After Eighty study) Nicolai Tegn, Michael Abdelnoor,
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Benefit of Early Invasive Therapy in Acute Coronary.
Antiplatelet Therapy Recommendations (UPDATED) DR MAHMOOD DARGAHI INTERVENTIONAL CARDIOLOGIST.
Survival Benefits in Higher Risk Patients Coronary Revascularization has Revolutionized the Therapy of Ischemic Heart Disease Acute coronary syndromes.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Women and Cardiovascular Disease
Prehospital NSTEMI Patient Assessment and Treatment
CPR in ACUTE CORONARY SYNDROM
Risk Stratification of Chest Pain: Best Practices
CORONARY ARTERY DISEASE
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
On behalf of J. Belardi, M. Leon, L. Mauri,
Unstable Angina and Non–ST Elevation Myocardial Infarction
This series of slides highlights a report on a symposium at the European Society of Cardiology Congress held in Munich, Germany from August 28 to September.
European Heart Association Journal 2007 April
Section 5: Intervention and drug therapy
Section F: Clinical guidelines
Invasive versus conservative treatment in unstable coronary syndromes
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
The European Society of Cardiology Presented by RJ De Winter
Global Registry of Acute Coronary Events: GRACE
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative Post AMI Care

Savonitto S, Ardissino D, Granger CB, et al. JAMA 1999;281:707–13 (127) Kaplan-Meier Estimates of Probability of Death Based on Admission Electrocardiogram

Antman EM, Tanasijevic MJ, Thompson B, et al. N Engl J Med 1996;335:1342–9 (201) Troponin I Levels to Predict the Risk of Mortality in Acute Coronary Syndromes

TIMI Risk Score – Cardiac Events by 14 Days (TIMI 11B, ESSENCE)

RISK SCORES TIMIGRACE History Age Hypertension Diabetes Smoking ↑ Cholesterol Family history History of CAD Age Presentation Severe angina Aspirin within 7 days Elevated markers ST-segment deviation Heart rate Systolic BP Elevated creatinine Heart failure Cardiac arrest Elevated markers ST-segment deviation Antman EM, et al. JAMA 2000;284:835–42. Eagle KA, et al. JAMA 2004;291:2727–33. GRACE = Global Registry of Acute Coronary Events; TIMI = Thrombolysis in Myocardial Infarction.

GRACE Prediction Score – All-cause Mortality Within 6 Months of Discharge Eagle KA, Lim MJ, Dabbous OH, et al. JAMA 2004;291: (168)

Acute Coronary Syndromes Invasive vs Conservative Pathophysiology Diagnosis Initial Therapy Risk-Stratification Invasive vs Conservative Discharge Planning

Choose A Strategy Initial Conservative – Angiography only if patient fails medical management (refractory or resting angina) or has objective evidence of ischemia (stress testing) Initial Invasive – Angiography before failure of medical management or stress testing – Immediate angiography (ISAR-COOL) or – Deferred Angiography (all other trials – 12-48h)

Choose A Strategy - Rationale Initial Conservative – Early trials demonstrate similar efficacy (TIMI IIIB, MATE, VANQWISH, RITA-2) – Aggressive antiplatelet and anticoagulant therapy has reduced events Initial Invasive – Rapidly identify the 10-20% with nonocclusive CAD and the 20% with 3v CAD

Less Events in Early Invasive Strategy

SELECTION OF INITIAL TREATMENT STRATEGY: INITIAL INVASIVE VERSUS CONSERVATIVE STRATEGY InvasiveRecurrent angina/ischemia at rest with low-level activities despite intensive medical therapy Elevated cardiac biomarkers (TnT or TnI) New/presumably new ST-segment depression Signs/symptoms of heart failure or new/worsening mitral regurgitation High-risk findings from noninvasive testing Hemodynamic instability Sustained ventricular tachycardia PCI within 6 months Prior CABG High risk score (e.g., TIMI, GRACE) Reduced left ventricular function (LVEF < 40%) ConservativeLow risk score (e.g., TIMI, GRACE) Patient/physician preference in the absence of high-risk features

Choose A Strategy – Guidelines Initial invasive – Refractory angina or hemodynamic/electrical instability (Class I, B) – Initially stabilized patients without contraindications and with elevated risk for events (Class I, A) Initial Conservative – May be considered in patients with elevated risk (Class IIb,B) – May consider physician or patient preference (Class IIb,C) – Women with low-risk features (Class I, B)

Selection of Strategy: Invasive vs. Conservative Strategy (1) An early invasive strategy (i.e., diagnostic angiography with intent to perform revascularization) is indicated with refractory angina or hemodynamic or electrical instability (I, B).

Selection of Strategy: Invasive vs. Conservative Strategy (2) An early invasive strategy is indicated in initially stabilized patients (without serious comorbidities or contraindications to such procedures) who have an elevated risk for clinical events (I, A). Scores indicating elevated risk include combinations of the following: – Recurrent angina/ischemia at rest or low-level activities – Elevated cardiac biomarkers – New/presumably new ST-segment depression – Signs or symptoms of HF or new/worsening mitral regurgitation – High-risk findings from noninvasive testing – Hemodynamic instability – Sustained ventricular tachycardia – PCI within 6 months – Prior CABG – High risk score – LVEF < 0.40

Selection of Strategy: Invasive vs. Conservative Strategy (3) In initially stabilized patients, an initially conservative (i.e., a selectively invasive) strategy may be considered in patients (without serious comorbidities or contraindications to such procedures) who have an elevated risk for clinical events, including those who are troponin-positive (IIb, B). The decision to implement an initial conservative strategy may consider physician and patient preferences (IIb, C). A conservative strategy is recommended in women with low-risk features (I, B).

SELECT MANAGEMENT STRATEGY: INITIAL INVASIVE VERSUS INITIAL CONSERVATIVE STRATEGY